SEC Tracker
Get the app

AEON Biopharma AEON

AEON Biopharma Biopharma to hold special meeting

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting on Dec 15, 2026
  2. Proposals include reverse stock split authority
  3. Amendments to equity incentive and ESPP plans

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when AEON Biopharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Biovie BIVI public float $8M, Dec 31, 2025
  3. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  4. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  5. Talphera TLPH public float $8M, Jun 30, 2025